Chemokines in triple-negative breast cancer heterogeneity: New challenges for clinical implications
- 9 March 2022
- journal article
- research article
- Published by Elsevier in Seminars in Cancer Biology
- Vol. 86 (Pt 2) , 769-783
Abstract
No abstract availableKeywords
This publication has 196 references indexed in Scilit:
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- The Life History of 21 Breast CancersCell, 2012
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroupsNature, 2012
- Genome remodelling in a basal-like breast cancer metastasis and xenograftNature, 2010
- Ki67 in breast cancer: prognostic and predictive potentialThe Lancet Oncology, 2010
- Unexpected Pieces to the Senescence PuzzleCell, 2008
- Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replicationNature, 2006
- Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpointsNature, 2006
- High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analysesInternational Journal of Cancer, 2005
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005